Skip to main content
Charles River LaboratoriesPartnership

Charles River Laboratories and MEDIPOST sign non-exclusive MOU to advance GMP Testing Solutions.

What happened

Charles River Laboratories International partners with Medipost Co..

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Charles River Laboratories and MEDIPOST sign non-exclusive MOU to advance GMP Testing Solutions. Partnership showcases a forward-looking collaboration model that highlights advanced testing expertise WILMINGTON, Mass.-(BUSINESS WIRE)-$CRL #CDMO-Charles River Laboratories (CRL) and MEDIPOST Co., Ltd. (KOSDAQ 078160) have entered into a strategic, non-exclusive Memorandum of Understanding (MOU) to collaborate on GMP-compliant testing, as well as broader commercial and marketing efforts to advance cell therapy development and commercialization. The partnership will leverage Charles River's expertise in biologics and cell therapy GMP testing to support MEDIPOST's global cell therapy pipeline, starting in the Asia-Pacific (APAC) and North America (NA) regions, with possible expansion into Middle East and Europe. "We are excited to deepen our partnership with MEDIPOST and collaborate with a top global cell therapy developer, assisting at both clinical and commercialization phases," said Kerstin Dolph, Corporate Senior Vice President, Global Manufacturing, Charles River. "By collaborating with industry leaders, we aim to expand GMP testing capabilities and help ensure that safe, compliant products reach patients more efficiently." Charles River will provide specialized expertise in biologics quality control, viral testing, release testing, and other GMP-compliant services...

Keep reading with a free account

The rest of this article, and every signal for Charles River Laboratories, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Partnership

What this signalsA new partnership often opens integration and co-selling work.

Companies

  • Medipost Co.Partnermedi-post.com

More partnership signals at other companies

The full record

From the Signal API record

Extraction

Confidence
42%
Detected
May 13, 2026
signal_type
news
signal_subtype
partners_with

Use this data

Get every partnership signal for Charles River Laboratories and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Charles River Laboratories this week?”

  2. Send it to your own tools

    The Signal API returns partnership signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/b7e09923-d7ce-4fbf-bc34-1af0d23ab046 returns this record as JSON. POST /v1/companies/enrich returns every signal for crl.com.

{
  "signal_id": "b7e09923-d7ce-4fbf-bc34-1af0d23ab046",
  "signal_type": "news",
  "signal_subtype": "partners_with",
  "detected_at": "2026-05-13T15:00:00+00:00",
  "company": {
    "name": "Charles River Laboratories",
    "domain": "crl.com"
  },
  "data": {
    "url": "https://healthtechhotspot.com/charles-river-laboratories-and-medipost-sign-non-exclusive-mou-to-advance-gmp-testing-solutions",
    "title": "Charles River Laboratories and MEDIPOST sign non-exclusive MOU to advance GMP Testing Solutions.",
    "excerpt": "Charles River Laboratories and MEDIPOST sign non-exclusive MOU to advance GMP Testing Solutions.\n\nPartnership showcases a forward-looking collaboration model that highlights advanced testing expertise\n\nWILMINGTON, Mass.-(BUSINESS WIRE)-$CRL #CDMO-Charles River Laboratories (CRL) and MEDIPOST Co., Ltd. (KOSDAQ 078160) have entered into a strategic, non-exclusive Memorandum of Understanding (MOU) to collaborate on GMP-compliant testing, as well as broader commercial and marketing efforts to advance cell therapy development and commercialization. The partnership will leverage Charles River's expertise in biologics and cell therapy GMP testing to support MEDIPOST's global cell therapy pipeline, starting in the Asia-Pacific (APAC) and North America (NA) regions, with possible expansion into Middle East and Europe.\n\n\"We are excited to deepen our partnership with MEDIPOST and collaborate with a top global cell therapy developer, assisting at both clinical and commercialization phases,\" said Kerstin Dolph, Corporate Senior Vice President, Global Manufacturing, Charles River. \"By collaborating with industry leaders, we aim to expand GMP testing capabilities and help ensure that safe, compliant products reach patients more efficiently.\"\n\nCharles River will provide specialized expertise in biologics quality control, viral testing, release testing, and other GMP-compliant services...",
    "summary": "Charles River Laboratories International partners with Medipost Co..",
    "planning": false,
    "image_url": "https://mms.businesswire.com/media/20260513434668/en/2798878/22/Charles_River_and_MEDIPOST_Signed_MoU.jpg",
    "confidence": 0.4189,
    "published_at": "2026-05-13T15:00:00Z",
    "article_sentence": "Charles River Laboratories and MEDIPOST sign non-exclusive MOU to advance GMP Testing Solutions.",
    "related_company_name": "Medipost Co.",
    "related_company_domain": "medi-post.com"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.